Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
First ambulance arrived in 13 minutes; at time of fire the system had more calls than ambulances available
Tranexamic acid has been used in trauma centers for years, and the drug is making its way into the prehospital setting
A 70 percent price hike has advocates worried it will limit the amount of narcan departments can afford to purchase
The cliché “knowledge is power” is essential to EMS.
Man was fired from EMT job as soon as accusation of stealing patient’s medications, captured on surveillance video, was made
Manufacturer rebate is available for public agency naloxone purchases for next year
Cardiac arrest resuscitation was unsuccessful; EMS, police, and fire personnel returned to patient’s home to shovel off the roof
He ran into a building filled with smoke and helped rescue an elderly man; he also treated a woman for smoke inhalation
Marathon halted due to extreme heat; 75 runners treated on the scene
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.